Episodes

Latest Episode
Communicable E46: Steroids for pneumocystis pneumonia

Communicable E46: Steroids for pneumocystis pneumonia

S2E46 · · 55:14

In this episode of Communicable, Navaneeth Narayanan and Josh Nosanchuk invite Virginie Lemiale and Elie Azoulay (Paris, France) as well as fellow editor Emily McDonald (Montreal, Ca...

Communicable E45: Top infectious diseases papers in 2025

Communicable E45: Top infectious diseases papers in 2025

S2E45 · · 38:44

In this episode of Communicable, Josh Davis (Newcastle, Australia) and Emily McDonald (Montreal, Canada), plus invited guest, Steven Tong (Melbourne, Australia)—all practicing physic...

Communicable E44: Top clinical microbiology papers in 2025

Communicable E44: Top clinical microbiology papers in 2025

S2E44 · · 01:10:53

In the first Communicable episode of 2026, Annie Joseph and Josh Nosanchuk invite Robin Patel (Rochester, USA) and Fidelma Fitzpatrick (Dublin, Ireland) to discuss some of their favo...

Communicable E43: Katie's picks

Communicable E43: Katie's picks

S2E43 · · 47:23

In this final episode of 2025, hosts Annie Joseph (Nottingham, UK) and Angela Huttner (Geneva, Switzerland), interview Communicable's producer, Katie Hostettler-Oi (Zurich, Switzerla...

Communicable E42: Should doctors stay at X (Twitter) or leave it?

Communicable E42: Should doctors stay at X (Twitter) or leave it?

S2E42 · · 01:05:03

During the COVID-19 pandemic with lockdown mandates and social distancing, doctors, researchers, and the public were able to find refuge and community online; for the infectious dise...

Communicable E41: Diagnostic stewardship

Communicable E41: Diagnostic stewardship

S2E41 · · 01:02:07

In the last ten years, 'diagnostic stewardship' has emerged as a core principle of good clinical practice whose implementation impacts both the individual patient and public health a...

Communicable E40: AMR in conflict and crisis zones

Communicable E40: AMR in conflict and crisis zones

S2E40 · · 57:24

It’s World AMR Awareness Week (WAAW) and we have prepared a special episode in light of that. In this week's Communicable, Navaneeth Narayanan and Thomas Tängdén host Aula Abbara (Lo...

Communicable E39: Dengue on the rise

Communicable E39: Dengue on the rise

S2E39 · · 56:51

Once confined to the tropics, dengue is spreading via its vector, the Aedes mosquito, to more temperate regions, causing increases in global morbidity, mortality and cost. In 2019, t...

Communicable E38: Why do you have to be so complicated? The 2025 IDSA Complicated UTI Guidelines

Communicable E38: Why do you have to be so complicated? The 2025 IDSA Complicated UTI Guidelines

S2E38 · · 48:13

In this episode of Communicable, Erin McCreary and Angela Huttner are joined by Barbara Trautner (St. Louis, USA) and Valéry Lavergne (Vancouver, Canada), the co-chairs and leading a...

Communicable E37: 'Peer review is broken'

Communicable E37: 'Peer review is broken'

S2E37 · · 01:07:02

Contrary to popular belief, peer review has only recently become an integral step in scientific publishing. Currently seen by many as a badge of honour ensuring valid, innovative and...

Communicable E36: Finding BALANCE in antibiotic durations—the BALANCE trial

Communicable E36: Finding BALANCE in antibiotic durations—the BALANCE trial

S2E36 · · 01:09:33

In this second-ever collaboration between SIDP’s Breakpoints and ESCMID’s Communicable podcasts, hosts Erin McCreary and Angela Huttner invite the two principal investigators and vis...

Communicable E35: From Ebola to COVID-19 — Graham and Kobinger on building vaccines

Communicable E35: From Ebola to COVID-19 — Graham and Kobinger on building vaccines

S2E35 · · 58:13

In this episode of Communicable, Angela Huttner and Erin McCreary invite two titans of vaccinology, Barney Graham (Atlanta, USA), former deputy director of the NIH NIAID Vaccine Rese...

Communicable E34: WHO's Fungal Priority Pathogens List

Communicable E34: WHO's Fungal Priority Pathogens List

S2E34 · · 50:24

Fungal infections and disease have long been overlooked in terms of healthcare burden, with poor diagnostics and limited options for treatment and management. In 2022, the WHO publis...

Communicable E33: Ethics in infectious diseases

Communicable E33: Ethics in infectious diseases

S2E33 · · 36:51

Ethics in the field of infectious disease can be a delicate interplay between treating the individual patient and protecting the collective health of a society. Sometimes these two m...

Communicable E32: Fluoroquinolones - to heal or harm?

Communicable E32: Fluoroquinolones - to heal or harm?

S2E32 · · 55:56

Fluoroquinolones (FQs) are valuable given their broad-spectrum activity against Gram-positive and Gram-negative bacteria and their high penetration into various tissues. Yet FQs have...

Communicable E31: Climate change and fungal spread

Communicable E31: Climate change and fungal spread

S2E31 · · 51:53

The adaptability of fungi to warmer temperatures is an obvious consequence of climate change. Perhaps less obvious is the role climate change has played on fungal pathogens emerging ...

Communicable E30: WHO's first-ever guideline on meningitis

Communicable E30: WHO's first-ever guideline on meningitis

S2E30 · · 01:00:57

Meningitis remains a major global health threat, with an estimated 2.5 million cases each year; of these, one in six results in death and one in five in long-term disabilities. Altho...

Communicable E29: Bacterial vaginosis & male partners

Communicable E29: Bacterial vaginosis & male partners

S2E29 · · 59:33

Bacterial vaginosis (BV) was long considered not to be a sexually transmitted infection (STI), and treatment was only for women to bear. That was the convention at least until Catrio...

Communicable E28: Late-breaker trials at ESCMID Global: Should they change your practice? - part 2

Communicable E28: Late-breaker trials at ESCMID Global: Should they change your practice? - part 2

S2E28 · · 47:22

Editors of CMI Comms, Josh Davis, Erin McCreary and Emily McDonald return for round 2 taking turns to summarise and discuss late-breaker trials presented at ESCMID Global 2025 in Vie...

Communicable E27: Late-breaker trials at ESCMID Global: Should they change your practice? - part 1

Communicable E27: Late-breaker trials at ESCMID Global: Should they change your practice? - part 1

S2E27 · · 53:38

This episode of Communicable takes on a special format where editors of CMI Comms, Marc Bonten, Josh Davis, Erin McCreary, Emily McDonald, all clinical trialists in their own right, ...